Vanda Pharmaceuticals (VNDA) Tops Q4 EPS by 8c
Tweet
Share
E-mail
Get Alerts VNDA Hot Sheet
Price: $5.22 +3.78%
Financial Fact:
Total operating expenses: 39.14M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Total operating expenses: 39.14M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q4 EPS of ($0.01), $0.08 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $38.24 million versus the consensus estimate of $38.39 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight
- JPMorgan Downgrades JD Logistics Inc (2618:HK) (JDLGF) to Neutral
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
